VolitionRX (id:193 VNRX)
0.820 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 1:26:07 PM)
Exchange open, closes in 2 hours 33 minutes
9.20 USD (9.20%)
17.16 USD (17.16%)
18.86 USD (18.86%)
13.90 USD (13.90%)
7.91 USD (7.91%)
-84.29 USD (-84.29%)
-78.42 USD (-78.42%)
-70.71 USD (-70.71%)
About VolitionRX
Market Capitalization 61.49M
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
| Headquarters (address) |
1489 West Warm Springs Road Henderson 89014 NV United States |
| Phone | 646 650 1351 |
| Website | https://www.volition.com |
| Employees | 101 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | VNRX |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 0.430 - 1.23 |
| Market Capitalization | 61.49M |
| P/E trailing | -1.34 |
| P/E forward | -4.15 |
| Price/Sale | 62.97 |
| Price/Book | -2.60 |
| Beta | 1.10 |
| EPS | -0.400 |
| EPS United States (ID:6, base:3389) | 24.33 |